register

News & Trends - Pharmaceuticals

Medicines Australia to host first horizon scanning forum to explore medicines of tomorrow

Health Industry Hub | November 14, 2022 |

Pharma News: An inaugural event in Canberra next month will explore the future of medicines, biotherapeutics and treatments. ‘Medicines of Tomorrow: The First Horizon Scanning Forum’, will be hosted by Medicines Australia, the research-driven pharmaceutical industry body.

For the first time, experts in medicines development, health policy, federal, state and territory government and patient advocacy will come together to view disruptive medical innovations in the international innovation pipeline – and consider how Australia’s health system needs to evolve to prepare for them.

The Medical Futurist, Dr Bertalan Meskó, will deliver the keynote address virtually and says there must be a cultural transformation to prepare for the latest health innovations.

“COVID-19 shattered our lives, and our preconceived ideas of what healthcare looks like. There are infinite possibilities with technologies such as digital health and A.I. – and we are only scratching the surface,” Dr Meskó said.

Call for a horizon scanning framework that is future proof, agile and moves with the age of precision medicine

“I am honoured to be addressing the first ‘Medicines of Tomorrow’ in Australia on 6 December. We are all patients at some point in our lives. There must be a cultural movement that brings our health systems into the 21st century – and the world is watching,” Dr Meskó said.

CEO of Medicines Australia, Elizabeth de Somer, said ‘Medicines of Tomorrow’ will showcase innovative medicines and technologies on the horizon in the short to medium term, but long-term vision is also needed to prepare us for the future.

“‘Medicines of Tomorrow’ is the first-time health experts, clinicians, federal and state governments, the medicines industry, and patient groups have come together on a national stage.

“The medicines industry has made leaps and bounds in rapidly discovering and developing disruptive medicines, vaccines and therapies. Australia must prepare now to ensure patients have rapid access to these technologies. Attendees can expect to hear about innovations just around the corner that could dramatically change the outcomes of deadly, debilitating and chronic diseases.

“Regular horizon scanning is a key part of the Strategic Agreement between Medicines Australia and the Commonwealth Government. The ‘Medicines of Tomorrow’ event will open the dialogue towards a nationally coordinated, future-focused, adaptable system that benefits all Australian patients,” Ms de Somer said.

Register here for in-person or virtual attendance to ‘Medicines of Tomorrow: The First Horizon Scanning Forum’.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - Biotechnology

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

Health Industry Hub | April 23, 2024 |

Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]

More


News & Trends - MedTech & Diagnostics

Federal government invests in Siemens Healthineers scanner to 'reduce wait times' for cancer diagnosis

Federal government invests in Siemens Healthineers scanner to ‘reduce wait times’ for cancer diagnosis

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: The Albanese Government is investing $12 million through the 2024–25 Budget, to purchase and install a […]

More


News & Trends - MedTech & Diagnostics

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: Starting from July 2024, Cardiac Implantable Electronic Devices (CIED) listed on the Prescribed List (PL) will […]

More


News & Trends - Biotechnology

CSL's world-first gene therapy heads for MSAC assessment

CSL’s world-first gene therapy heads for MSAC evaluation

Health Industry Hub | April 23, 2024 |

Biotech News: CSL’s world-first gene therapy for haemophilia B is scheduled for consideration at the upcoming Medical Services Advisory Committee (MSAC) […]

More


This content is copyright protected. Please subscribe to gain access.